Neurology startup merges with Wilbur Ross-backed SPAC

Aprinoia Therapeutics, a biotech with an Alzheimer’s disease drug in late-stage testing, plans to go public through a merger with a special purpose acquisition company, or SPAC, founded by former U.S. Commerce Secretary Wilbur Ross.